Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of the Glucose Transporter (GLUT3, SLC2A3) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A3 WT-OE cells (PubChem AID: 1794827)
Assay data:1 Active, 4 Tested
SummaryCompounds, ActiveRelated BioAssays by Target
Inhibition of the Glucose Transporter (GLUT4, SLC2A4) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A4 WT-OE cells (PubChem AID: 1794828)
Assay data:3 Active, 4 Tested
Inhibition of the Glucose Transporter (GLUT2, SLC2A2) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A2 WT-OE cells (PubChem AID: 1794829)
Assay data:4 Tested
SummaryRelated BioAssays by Target
Inhibition of the Glucose Transporter (GLUT1, SLC2A1) as assessed by a FRET based flow cytometry assay using a genetically-encoded biosensor for measuring free glucose (FLII12Pglu-700uDelta6) in HEK293 JumpIN TRex SLC2A1 WT-OE cells (PubChem AID: 1794830)
Assay data:2 Active, 1 Activity ≤ 1 µM, 4 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Inhibition of yeast alpha-glucosidase
Assay data:1 Active, 2 Tested
SummaryCompounds, ActivePubMed Citation
Flow cytometry transport assay for SLC2A1 using HEK293 JumpIN TRex SLC2A1 WT-OE cells
Assay data:3 Active, 1 Activity ≤ 1 µM, 4 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Flow cytometry transport assay for SLC2A2 using HEK293 JumpIN TRex SLC2A2 WT-OE cells
SummaryCompounds, ActiveRelated BioAssays by DepositorRelated BioAssays by Target
Flow cytometry transport assay for SLC2A4 using HEK293 JumpIN TRex SLC2A4 WT-OE cells
Assay data:4 Active, 4 Tested
Flow cytometry transport assay for SLC2A3 using HEK293 JumpIN TRex SLC2A3 WT-OE cells
Assay data:2 Active, 4 Tested
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
Assay data:2 Activity ≤ 1 µM, 4309 Tested
SummaryCompounds, activity ≤ 1 µM
Induction of insulin secretion in human pancreatic islets at 2 to 12 mM
Assay data:1 Active, 1 Tested
Binding affinity to V5-His tagged FIBCD1 ecto-domain (54 to 461 residues) (unknown origin) expressed in HEK293 cells assessed as reduction in binding between FIBCD1 and acetylated BSA by ELISA
Assay data:16 Tested
Binding affinity to V5-His tagged FIBCD1 ecto-domain (54 to 461 residues) (unknown origin) assessed as reduction in binding between FIBCD1 and acetylated BSA at 50 mM by ELISA relative to control
Assay data:9 Tested
Inhibition of GLUT1-mediated 2NBDG uptake in human Caco2 cells at 1 to 10 mM after 10 mins by Hoechst 33342 staining based fluorescence assay
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status
Assay data:929 Tested
SummaryPubMed Citation
Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index
Substrate activity at hexokinase (unknown origin) assessed as compound phosphorylation after 1 days in presence of ATP by 31-P NMR spectroscopic analysis
Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits)
Assay data:1629 Tested
Summary
Inhibition of Escherichia coli Heptosyltransferase I assessed as reduction in ADP release using ODLA and ADP-heptose substrates in presence of phospho(enol)pyruvate and NADH by pyruvate kinase and LDH based ADP/NADH coupling assay
Assay data:8 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of Escherichia coli Heptosyltransferase I assessed as reduction in ADP release at 1 mM using ODLA and ADP-heptose substrates in presence of phospho(enol)pyruvate and NADH by pyruvate kinase and LDH based ADP/NADH coupling assay
Assay data:21 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on